Global and Japan Piperacillin Sodium (CAS 59703-84-3) Market Insights, Forecast to 2027

Piperacillin Sodium is the sodium salt of piperacillin, a broad-spectrum semisynthetic, ampicillin-derived ureidopenicillin antibiotic with bactericidal activity.
The classification of Piperacillin Sodium includes Piperacillin Sodium and Piperacillin and Tazobactam. The proportion of Piperacillin and Tazobactam in 2019 is about 78%, and the proportion is in increasing trend from 2015 to 2020.
Piperacillin Sodium is widely used in Piperacillin Sodium Injection and Piperacillin Sodium Compound Injection. The most proportion of Piperacillin Sodium is used in Piperacillin Sodium Compound Injection and the proportion in 2019 is about 86%.
China is the largest supply country, it account about 47% of global production in 2019, India is the second largest country with 33% of global share.
Asia-Pacific is the largest consumption market, with a market share nearly 84% in 2019. Following Asia-Pacific, Europe is the second largest consumption market with the market share of 12%.
Qilu Pharmaceutical, Pfizer Healthcare, Fresenius Kabi AG, Aurobindo Pharma, Sandoz Inc, NCPC s, etc. are the leaders of the industry.

Market Analysis and Insights: Global and Japan Piperacillin Sodium (CAS 59703-84-3) Market
This report focuses on global and Japan Piperacillin Sodium (CAS 59703-84-3) market.
In 2020, the global Piperacillin Sodium (CAS 59703-84-3) market size was US$ 196.7 million and it is expected to reach US$ 210 million by the end of 2027, with a CAGR of 0.9% during 2021-2027. In Japan the Piperacillin Sodium (CAS 59703-84-3) market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Piperacillin Sodium (CAS 59703-84-3) Scope and Market Size
Piperacillin Sodium (CAS 59703-84-3) market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Piperacillin Sodium (CAS 59703-84-3) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Piperacillin Sodium (CAS 59703-84-3) market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type
Piperacillin
Piperacillin and Tazobactam

Segment by Application
Piperacillin Sodium Injection
Piperacillin Sodium Compound Injection

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Qilu Pharmaceutical
Pfizer Healthcare
Fresenius Kabi AG
Aurobindo Pharma
Sandoz Inc
NCPC
REYOUNG
Yuhan Corporation
LKPC
Nectar Lifesciences
Sterile India
Suanfarma
Rajasthan Antibiotics